- Home
- COF vs SYK Comparison
COF vs SYK Comparison
Compare COF & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COF
- SYK
- Stock Information
- Founded
- COF 1988
- SYK 1941
- Country
- COF United States
- SYK United States
- Employees
- COF N/A
- SYK N/A
- Industry
- COF Major Banks
- SYK Medical/Dental Instruments
- Sector
- COF Finance
- SYK Health Care
- Exchange
- COF Nasdaq
- SYK Nasdaq
- Market Cap
- COF 144.9B
- SYK 140.9B
- IPO Year
- COF 1994
- SYK N/A
- Fundamental
- Price
- COF $213.73
- SYK $369.32
- Analyst Decision
- COF Buy
- SYK Buy
- Analyst Count
- COF 16
- SYK 19
- Target Price
- COF $243.13
- SYK $428.22
- AVG Volume (30 Days)
- COF 3.2M
- SYK 1.5M
- Earning Date
- COF 10-21-2025
- SYK 10-30-2025
- Dividend Yield
- COF 1.13%
- SYK 0.91%
- EPS Growth
- COF N/A
- SYK N/A
- EPS
- COF N/A
- SYK 7.55
- Revenue
- COF $23,773,000,000.00
- SYK $23,818,000,000.00
- Revenue This Year
- COF $94.82
- SYK $11.71
- Revenue Next Year
- COF $18.43
- SYK $8.47
- P/E Ratio
- COF N/A
- SYK $48.87
- Revenue Growth
- COF N/A
- SYK 11.36
- 52 Week Low
- COF $143.22
- SYK $329.16
- 52 Week High
- COF $232.45
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- COF 39.70
- SYK 40.29
- Support Level
- COF $210.30
- SYK $352.65
- Resistance Level
- COF $217.21
- SYK $373.50
- Average True Range (ATR)
- COF 5.03
- SYK 6.81
- MACD
- COF -1.43
- SYK -0.40
- Stochastic Oscillator
- COF 25.16
- SYK 54.24
About COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending still provides the majority of the bank's revenue.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.